Ionis Pharmaceuticals Inc is a pioneer in creating RNA-targeted therapeutics. With a focus on serious and rare diseases, it has brought to market treatments like SPINRAZA for spinal muscular atrophy and TEGSEDI for polyneuropathy caused by hereditary transthyretin amyloidosis. The company is also advancing a robust pipeline of medicines targeting conditions such as amyotrophic lateral sclerosis, cardiovascular disease, and hepatitis B, among others. Ionis collaborates with leading pharmaceutical companies to enhance its reach and impact. Based in Carlsbad, California, Ionis continues to push the boundaries of medical science.

IONS Articles